I am a physician-scientist with formal training in both clinical radiology and molecular imaging research.
I received my medical degree and doctorate from the Humboldt University in Berlin, Germany. I completed a diagnostic radiology residency at Beth Israel Deaconess Medical Center/Harvard Medical School (where I also served as chief resident), as well as subspecialty training in magnetic resonance imaging (MRI) at Stanford University. I pursued postdoctoral training at the Center for Molecular Imaging Research at Massachusetts General Hospital/Harvard Medical School (with Ralph Weissleder) and at the Molecular Imaging Program at Stanford (with Sam Gambhir).
My clinical interests lie in the imaging of the abdomen and pelvis, with a focus on the evaluation of the liver, biliary tree, and pancreas. In particular, this involves the use of MRI and CT.
My laboratory focuses on the development of novel molecular imaging approaches, with the goal of facilitating earliest cancer detection and combined pre- and intraoperative tumor visualization. This involves the design of novel multimodality nanoparticle probes that can be detected by both MRI and “Surface Enhanced (Resonant) Raman Spectroscopy” (SE(R)RS). SERS imaging is an emerging technique that allows specific detection of a nanoparticle in the body because of its unique Raman signature, and with higher sensitivity than any other method. Multi-modality approaches allow both whole-body staging and ultrasensitive intraoperative detection of cancer (Kircher et al, Nature Medicine, 2012,18:829-34).
A second research interest is the development of novel methods for the non-invasive tracking of cell migration. Such techniques are important in designing and monitoring cell-based therapies and in elucidating fundamental mechanisms of cancer (Kircher et al, Nature Reviews Clinical Oncology, 2011,27;8:677-88).
My lab is currently funded by the National Institutes of Health; The Dana Foundation; the Radiological Society of North America (RSNA); the Geoffrey Beene Cancer Research Center, theBrain Tumor Center, and the Nanotechnology Center at Memorial Sloan Kettering; and The Society of Memorial Sloan Kettering Cancer Center. I have received research awards from the RSNA, the World Molecular Imaging Society, the Dana Foundation, the American Heart Association, and Harvard Medical School. I am a member of the RSNA, the World Molecular Imaging Society, the International Society for Magnetic Resonance in Medicine, the American Roentgen Ray Society, and the Association of University Radiologists.
- Clinical Expertise: Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) of the Chest, Abdomen, and Pelvis
- Languages Spoken: English
- Education: MD, PhD, Humboldt University, Berlin (Germany)
- Residencies: Beth Israel Deaconess Medical Center/Harvard Medical School
- Fellowships: Massachusetts General Hospital/Harvard Medical School; Stanford University Medical Center; Stanford University Molecular Imaging Program
- Board Certifications: Diagnostic Radiology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more